Sign in

CIK 0001534969

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261911522
Phone
+1 801-990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,563
in 6 filings

Net −$79,563. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-04-06 Kearney Paul Chief Data Officer Exercise or conversion · Stock Option (right to buy) −24,050 0
2023-03-07 CRITCHFIELD GREGORY C Chief Executive Officer Grant or award +62,200 857,145
2023-03-07 CRITCHFIELD GREGORY C Chief Executive Officer Grant or award · Stock Option (right to buy) +98,300 98,300
2023-03-06 Harrison Robert Gardner Chief Information Officer Grant or award +28,500 28,500
2023-03-06 Harrison Robert Gardner Chief Information Officer Grant or award · Stock Option (right to buy) +45,000 45,000
2023-03-06 Jackson Benjamin General Counsel Grant or award +24,700 32,700
2023-03-06 Jackson Benjamin General Counsel Grant or award · Stock Option (right to buy) +39,100 39,100
2023-03-06 MOYES JAY M Chief Financial Officer Grant or award +32,800 35,630
2023-03-06 MOYES JAY M Chief Financial Officer Grant or award · Stock Option (right to buy) +51,800 51,800
2023-03-06 Boniface John J. Chief Scientific Officer Grant or award +22,100 69,454
2023-03-06 Boniface John J. Chief Scientific Officer Grant or award · Stock Option (right to buy) +34,900 34,900
2023-03-06 Kearney Paul Chief Data Officer Grant or award +16,000 16,000
2023-03-06 Kearney Paul Chief Data Officer Grant or award · Stock Option (right to buy) +25,300 25,300
2023-03-06 Altomare Nadia Chief Commercial Officer Grant or award +18,300 18,300
2023-03-06 Altomare Nadia Chief Commercial Officer Grant or award · Stock Option (right to buy) +28,900 28,900
2023-03-06 Foley Michael R Chief Medical Officer Grant or award +27,000 27,000
2023-03-06 Foley Michael R Chief Medical Officer Grant or award · Stock Option (right to buy) +42,700 42,700
2022-09-08 Boniface John J. Chief Scientific Officer Exercise or conversion +844 $0.73 $616 47,354
2022-09-08 Boniface John J. Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −844 0
2022-07-27 Boniface John J. Chief Scientific Officer Exercise or conversion +1,000 $0.73 $730 47,510

Page 17 of 23 · 457 trades